Temasek completed the $85m investment in Molbio Diagnostics.

Temasek, a Singapore-based investment firm, completed the $85m investment in Molbio Diagnostics, a healthcare solutions provider. "These funds from the minority stake investment will be used for domestic and external business development, overseas market expansion, and research and development," Sriram Natarajan, Molbio Diagnostics Director and CEO.